Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines

Virus Research

Volumn 161, Issue 2, 2011, Pages 181-187

  Sharma, Anurag ^a   Bangari, Dinesh S ^a   Vemula, Sai V ^a   Mittal, Suresh K ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Adenovirus persistence; Bovine adenovirus; Gene therapy; Nonhuman adenovirus; Porcine adenovirus; Vector safety

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; BOVINE ADENOVIRUS; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN ADENOVIRUS; HUMAN CELL; NONHUMAN; PORCINE ADENOVIRUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TRANSGENE; VIRUS GENOME; VIRUS REPLICATION;

ADENOVIRUSES, PORCINE; ANIMALS; CATTLE; CELL LINE; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GENOME, VIRAL; GENOMIC INSTABILITY; GREEN FLUORESCENT PROTEINS; HUMANS; MASTADENOVIRUS; MICE; SWINE; TRANSGENES; VIRUS REPLICATION;

ADENOVIRIDAE; BOVINAE; BOVINE ADENOVIRUS; BOVINE ADENOVIRUS 3; HUMAN ADENOVIRUS; PORCINE ADENOVIRUS; SUS;

EID: 80053130908     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.08.002     Document Type: Article

References (30)

1. Bangari D.S., Mittal S.K. Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture. Virus Res. 2004, 105:127-136.
2. Bangari D.S., Mittal S.K. Porcine adenovirus serotype 3 internalization is independent of CAR and alpha(v)beta(3) or alpha(v)beta(5) integrin. Virology 2005, 332:157-166.
3. Bangari D.S., Mittal S.K. Current strategies and future directions for eluding adenoviral vector immunity. Curr. Gene Ther. 2006, 6:215-226.
4. Bangari D.S., Mittal S.K. Development of nonhuman adenoviruses as vaccine vectors. Vaccine 2006, 24:849-862.
5. Bangari D.S., Shukla S., Mittal S.K. Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture. Biochem. Biophys. Res. Commun. 2005, 327:960-966.
6. Bangari D.S., Sharma A., Mittal S.K. Bovine adenovirus type 3 internalization is independent of primary receptors of human adenovirus type 5 and porcine adenovirus type 3. Biochem. Biophys. Res. Commun. 2005, 331:1478-1484.
7. Ehrhardt A., Haase R., Schepers A., Deutsch M.J., Lipps H.J., Baiker A. Episomal vectors for gene therapy. Curr. Gene Ther. 2008, 8:147-161.
8. Ehrhardt A., Xu H., Kay M.A. Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivo. J. Virol. 2003, 77:7689-7695.
9. Elkon K.B., Liu C.C., Gall J.G., Trevejo J., Marino M.W., Abrahamsen K.A., Song X., Zhou J.L., Old L.J., Crystal R.G., Falck-Pedersen E. Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:9814-9819.
10. Glasgow J.N., Kremer E.J., Hemminki A., Siegal G.P., Douglas J.T., Curiel D.T. An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism. Virology 2004, 324:103-116.
11. Graham F.L., Smiley J., Russell W.C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 1977, 36:59-74.
12. Green M.R., Mackey J.K., Green M. Multiple copies of human adenovirus 12 genomes are integrated in virus-induced hamster tumors. J. Virol. 1977, 22:238-242.
13. Harui A., Suzuki S., Kochanek S., Mitani K. Frequency and stability of chromosomal integration of adenovirus vectors. J. Virol. 1999, 73:6141-6146.
14. Kafri T., Morgan D., Krahl T., Sarvetnick N., Sherman L., Verma I. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:11377-11382.
15. Knoblauch M., Schroer J., Schmitz B., Doerfler W. The structure of adenovirus type 12 DNA integration sites in the hamster cell genome. J. Virol. 1996, 70:3788-3796.
16. Kreppel F., Kochanek S. Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors. J. Virol. 2004, 78:9-22.
17. Li Y., Muruve D.A., Collins R.G., Lee S.S., Kubes P. The role of selectins and integrins in adenovirus vector-induced neutrophil recruitment to the liver. Eur. J. Immunol. 2002, 32:3443-3452.
18. Mittal S.K., Prevec L., Graham F.L., Babiuk L.A. Development of a bovine adenovirus type 3-based expression vector. J. Gen. Virol. 1995, 76:93-102.
19. Moffatt S., Hays J., HogenEsch H., Mittal S.K. Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy. Virology 2000, 272:159-167.
20. Reddy P.S., Idamakanti N., Babiuk L.A., Mehtali M., Tikoo S.K. Porcine adenovirus-3 as a helper-dependent expression vector. J. Gen. Virol. 1999, 80:2909-2916.
21. Russell W.C. Update on adenovirus and its vectors. J. Gen. Virol. 2000, 81:2573-2604.
22. Sambrook J., Russell D.W. Molecular Cloning: A Laboratory Manual 2001, Cold Harbor Press, Cold Spring Harbor, New York.
23. Sharma A., Bangari D.S., Tandon M., Pandey A., HogenEsch H., Mittal S.K. Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model. Virology 2009, 386:44-54.
24. Sharma A., Tandon M., Ahi Y.S., Bangari D.S., Vemulapalli R., Mittal S.K. Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses. Gene Ther. 2010, 17:634-642.
25. Sharma A., Tandon M., Bangari D.S., Mittal S.K. Adenoviral vector-based strategies for cancer therapy. Curr. Drug Ther. 2009, 4:117-138.
26. Stone D., Lieber A. New serotypes of adenoviral vectors. Curr. Opin. Mol. Ther. 2006, 8:423-431.
27. van Olphen A.L., Tikoo S.K., Mittal S.K. Characterization of bovine adenovirus type 3 E1 proteins and isolation of E1-expressing cell lines. Virology 2002, 295:108-118.
28. Vemula S.V., Mittal S.K. Production of adenovirus vectors and their use as a delivery system for influenza vaccines. Expert Opin. Biol. Ther. 2010, 10:1469-1487.
29. Yang Y., Nunes F.A., Berencsi K., Furth E.E., Gonczol E., Wilson J.M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:4407-4411.
30. Zeng M., Cerniglia G.J., Eck S.L., Stevens C.W. High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation. Hum. Gene Ther. 1997, 8:1025-1032.